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ATP-sensitive Potassium Channels Contribute to
Reactive Hyperemia in Humans
Peter F. Banitt. Paul Smits, Stephen B. Williams, Peter Ganz, Mark A. Creager.
Brigham and Women's Hospital, Boston, MA
Plasma endothelin-1, ET-1, and the precursor, big ET-1, are demonstrable
in healthy man and increase during e.g. myocardial infarction (Miyauchi et
al 1989). To study the vascular effects of big ET-1 infusion, and its possi-
ble conversion of ET-1, healthy subjects received big ET-l in doses of 4-8
pmol.kg-1.min-1 intravenously for 20 minutes. Blood samples were taken
from systemic arterial and pulmonary arterial as well as jugular, deep fore-
arm, hepatic and renal vein catheters for determination of cardiac output,
CO, splanchnic (ESBF) and renal (ERBF) blood flows (indicators: cardiogreen
and PAH) forearm blood flow (FBF, pletysmographyl. and big ET-1 and ET-1
like immuno-reactivity, (ET-1-LiI. Big ET-l infusion caused a decrease in heart
rate, HR, from 57 ± 4 to 45 ± 3 beats.min-1 (p < 0.001) and increase of
mean arterial pressure, MAP. from 86 ± 1.3 to 106 ± 3.2 mmHg (p < 0.001).
CO fell by 22 ± 5% (p < 0.01). Pulmonary, splanchnic and renal oxygen up-
takes were unchanged indicating that big ET-1 does not influence oxygen
consumption. The arterial-jugular venous oxygen difference was unchanged
indicating unchanged cerebral blood flow. FBF was unchanged. ERBF and
ESBF fell by approximately 40% (both p < 0.001). Only splanchnic and re-
nal tissues extract big ET-1 with fractional extractions of 23 ± 4 and 45 ±
4%. Intravenous infusion of big ET-1 increased arterial ET-1-Li from 4 to 8
pmol.I-1 (p < 0.001) and renal release of ET-1-Li from 1.50 ± 0.18 to 8.68 ±
0.64 pmol.min-1 (p < 0.001). Conclusion: Big ET-1 infusion causes falls in
HR and CO, increase in MAP and decreases in splanchnic and renal blood
flows. Uptakes of big ET-l were only noted in the renal and splanchnic re-
gions with two-fold higher values in the kidneys, p < 0.005. Only the kidney
showed increased release of ET-1-Li suggesting a unique renal capacity to
synthesize and release big ET-1 . Compared to ET-l infusion (Weitzberg et al
1991) big ET-l infusion causes, despite lower arterial plasma ET-1-Li levels,
more marked haemodynamic effects as reflected in drops in HR and CO and
more marked increase in MAP with more pronounced and long-lasting renal
vasoconstriction. In addition big-ET-1 had no effect on cerebral or skeletal
muscle blood flows while ET-l caused dilatations in these regions.
Activation of ATP-sensitive potassium channels (KATP) of vascular smooth
muscle causes hyperpolarization of the cell membrane and vasodilation. The
purposes of this study were 1) to determine whether KATP contribute to re-
active hyperemia following ischemia in humans, and 2) whether adenosine,
a metabolite present in ischemic muscle, activates KATP. Accordingly, we
studied the effect of tolbutamide (1 mM), a KATP inhibitor, on reactive hyper-
emic forearm blood flow in 12 normal subjects. Forearm blood flow (FBF)
was measured by venous occlusion plethysmography. Forearm ischemia
was produced by inflating a blood pressure cuff to suprasystolic pressures
for 5 minutes. Following cuff release FBF was measured during the reactive
hyperemic phase for 5 minutes. After a re-equilibration period the above pro-
tocol was repeated during intra-brachial artery infusion of either tolbutamide
1 mM (n ~ 6) or vehicle (n = 6). Blood flow was plotted vs. time and the area
under the curve was calculated after subtracting baseline flow. Tolbutamide
did not significantly alter basal FBF (2.5 ± 0.6 to 2.3 ± 1.0 ml/1 00 ml/minl, or
peak reactive hyperemic FBF (21.9 ± 9.2 to 22.6 ± 7.2 mill 00 ml!min) (each
p = ns). However, tolbutamide significantly attenuated total hyperemic flow
repayment; (156 ± 44 vs. 114 ± 32 mill 00 ml, p = 0.02). Vehicle did not
impair basal flow, peak reactive hyperemic flow or repayment. Tolbutamide
1 mM did not attenuate adenosine-induced(15-500 mM) increases in FBF (n
= 6). These data indicate that KATP contribute to vasodilation during reactive
hyperemia in humans. Activation of KATP is not mediated by adenosine.
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The Role of Estradiol 17P on Free Radical
Induced Vascular Myointimal Hyperplasia
Estradiol17P Protects Against
Homocysteine-induced Vascular Injury in Rat
Thoracic Aorta
Michel Y. Farhat, Brenda Dingaan, Michael E. Fader, Peter W. Ramwell.
Georgetown University. Washington, DC
Hyperhomocysteinemia produces atherosclerotic lesions with characteristic
endothelial desquamation and intimal smooth muscle cell IVSMCI prolifer-
ation. In vitro, homocysteine is cytotoxic to endothelial cells and recent ob-
servations suggest that it may directly stimulate VSMC proliferation. Estro-
gen, on the other hand, inhibits VSMC proliferation both in vivo and in vitro.
We evaluated the effect of estradiol 17f3 (E2f3) on homocysteine-induced
VSMC proliferation in arterial segments from the rat thoracic aorta. Seg-
ments were placed overnight in Dulbecco's Minimum Essential Medium,
supplemented with gentamycin (25 Itg/mll. glutamine (2 mMI and 0.4% fa-
tal bovine serum, before incubation for 30 hours with DL-homocysteine thi-
olactone (0.1-5.0 mM). Radiolabelled thymidine uptake was assessed in in-
tact and deendothelialized arterial segments, in presence of E2f3 (30 nM) or
vehicle (1 % ethanol). In deendothelialized segments homocysteine elicited
a concentration-dependent increase in 3H-thymidine uptake, expressed as
cpmlmg protein. Thymidine uptake increased from a basal value of 8694 ±
1465 to 36338 ± 2025, at 5 mM homocysteine concentration (p < 0.011.
Intact arterial segments showed a significantly attenuated response to ho-
mocysteine stimulation. On the other hand, incubation of deendothelialized
segments with E2f3 (30 nM) caused a significant inhibition of homocysteine-
stimulated response, without affecting basal 3H-thymidine incorporation.
These results provide evidence for a direct stimulatory effect of homocys-
teine on VSMC proliferation in rat aortic segments. Further, our data show
estradiol 17f3 protects against homocysteine-induced vascular injury, possi-
bly via a direct effect on VSMC.
lation or surgical removal of the thyroid gland. Following 2 months on a thy-
roid suppressive diet. the extent of neointimal regrowth was compared 14
days after balloon injury in hypothyroid rats (Group 1, n = 8, thyroid stimulat-
ing hormone ITSH) = 9.6 micro IU/ml) and animals maintained on a normal
diet (Group 2, n ~ 8). Neointima formation was significantly attenuated in
Group 1: intima/medial ratios were 0.904 ± 0.118 mm2 and 1.361 ± 0.061
mm2 in Groups 1 and 2 respectively, (p < 0.02). Additional experiments in
rats following thyroidectomy (n = 3) revealed a similar significant decrease
in neointima formation following balloon injury. This inhibitory effect of hy-
pothyroidism was maintained in animals who were also made hypercholes-
terolemic (Group 3, n = 8, TSH = 10.2 micro IU/ml, total cholesterol = 752
mg/dl, low-density lipoprotein = 674 mg/dl): intima/medial ratios were 1.361
± 0.061 mm2 and 0.822 ± 0.078 mm2, in Groups 2 and 3 respectively, p <
0.02. Prolonged (60 days) cholesterol feeding alone (Group 4, n = 8) as sus-
pected, did not result in elevated cholesterol levels, but also did not result
in significant differences in intimal thickness when compared to animals in
Group 2. These results suggest that thyroid hormone may be an important
co-mitogen for the proliferative response of the rat carotid artery to balloon
injury and may help partially explain the growth inhibitory effect of hypophy-
sectomy.
Sam Cathapermal, Mann Y. Leong-Son, Peter W. Ramwell. Georgetown University.
Washington, DC
Oxygen free radicals may be involved in vascular hyperplasia by promot-
ing smooth muscle cell proliferation, a response potentiated by endothelial
damage. Estradiol17f3 protects against vascular injury in experimental arte-
riosclerosis and inhibits proliferation of primary cultures of vascular smooth
muscle cells. We studied the in vitro effect of estradiol 17f3 on vascular
smooth muscle cell hyperplasia induced by the superoxide anions (OZ"). In-
tact and denuded rat aortic segments were incubated overnight at 37' C in
2 ml Eagle's minimal essential medium supplemented with gentamycin and
glutamine, without phenol red. The segments were challenged with either
vehicle alone or the Oz" generating system (Xanthine and xanthine oxidase)
for 4 hrs. We found that 0-" significantly enhanced 3H-thymidine incorpo-
ration, an effect potentiated by the absence of the endothelium (Intact ves-
sel 8.3 x 105 ± 0.1 x 105 vs denuded vessel 2.5 x 106 ± 1.3 x 105 P <
0.01). This effect was inhibited by superoxide dismutase. Estradiol 17f3 (30
nM) significantly inhibited free radical induced 3H-thymidine uptake in both
intact and denuded vessels. We conclude that an intact endothelium may
protect against free radical induced smooth muscle cell proliferation. Estra-
diol17f3 may also protect against free radical induced vascular proliferation
by a mechanism independent of the endothelium.
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